
Morgan Stanley says investors are overlooking Synopsys’s AI revenue potential. But the October 20 headline doesn’t explain the bank’s analysis or give a price target tied to that view.
The bank’s valuation opinion is the main news. The supplied information doesn’t include its estimates or assumptions. Synopsys shares closed at US$457.45, down 1.53% for the day.
Investor takeaway: Morgan Stanley sees an AI-related opportunity, but the available facts don’t show how large it is or when it could affect revenue.
Advertisement
Synopsys Inc
SNPS.US
SNPS.US
Synopsys Inc
Market cap
$85.78B
P/E
79.1x
52W high
$539.48
52W low
$362.55
1W change
-9.48%
Beta
1.21
Analyst Price Targets
Based on 25 analysts covering SNPS · as of Oct 21, 2026
Wall Street analysts forecast SNPS stock price to rise 31.1% over the next 12 months.
Consensus
Strong Buy4.76 / 5.00
Avg. Target
C$586.95
+31.1% Upside
Previously C$583.99 on Oct 19, 2026
Current Price
C$447.62
Last close
Analyst Breakdown (25 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SNPS's historical volatility
30-Day Vol
49.8%
Annualized
90-Day Vol
47.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$535.13
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$475.07 | C$400.01 – C$564.23 |
| 60 trading days | C$504.21 | C$395.35 – C$643.05 |
| 90 trading days | C$535.13 | C$397.28 – C$720.83 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Synopsys closed at US$457.45
Shares fell 1.53% during the session. Trading volume was 199,503 shares, compared with a 20-day average of 2,634,141.
Bull case
Morgan Stanley believes the market is overlooking a potential AI-related revenue opportunity for Synopsys.
Bear case
The headline provides no revenue forecast or supporting analysis. Synopsys shares also fell 1.53% in the latest session.
Morgan Stanley’s AI revenue view is the catalyst
The October 20 headline says Morgan Stanley considers Synopsys undervalued because investors are overlooking an AI revenue opportunity. This is the bank’s valuation view, not a company announcement or reported financial result.
The supplied information doesn’t include the bank’s reasoning, revenue estimates, or a price target tied to this view. A separate headline from the same day says Morgan Stanley raised its target on AI hopes, but it gives no revised figure or further details. Synopsys makes software and related technology for semiconductor design, but the available information doesn’t say how much AI-related business it has or could generate. Investors can visit the company’s stock page.
Advertisement
Shares fell on the day, with volume below average
Synopsys closed at US$457.45, down 1.53%. Reported volume was 199,503 shares, or 0.68 times the 20-day average of 2,634,141.
The supplied performance figures show the stock down 9.48% over one week, up 16.27% over one month, and down 6.83% year to date. These figures cover different periods and don’t show that Morgan Stanley’s view caused the share-price moves. The reported 52-week range is US$362.55 to US$539.48, putting the close at 54% of that range. The supplied valuation figures include a P/E of 79.0848 and a market capitalization of about US$85.8 billion.
The revenue case remains unquantified in the supplied facts
The key question is whether AI-related demand can generate revenue for Synopsys. The supplied information gives no forecast, timeline, or evidence to measure the opportunity.
A separate October 15 headline asks whether the company’s AI-focused design IP strategy can drive growth. An October 14 headline mentions AI chipmaking libraries in semiconductor workflows. Neither includes results or further details, so they offer context but don’t confirm the revenue case. Investors can follow the discussion on Synopsys’s stock page, while keeping Morgan Stanley’s opinion separate from reported company performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


